Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 3.
doi: 10.1016/j.ijnss.2020.03.009. Online ahead of print.

Optimization of the Intravenous Infusion Workflow in the Isolation Ward for Patients With Coronavirus Disease 2019

Affiliations
Free PMC article

Optimization of the Intravenous Infusion Workflow in the Isolation Ward for Patients With Coronavirus Disease 2019

Yan Song et al. Int J Nurs Sci. .
Free PMC article

Abstract

Objective: This study aimed to evaluate the effect of optimization of the intravenous infusion workflow in isolation wards for patients with coronavirus disease 2019.

Methods: The infusion management group optimized the intravenous infusion workflow based on Hamer's Process Reengineering Theory and applied it to the treatment of patients with coronavirus disease 2019. The work efficiency, patients' satisfaction and economic indicators before and after optimization were compared.

Results: After the infusion workflow was optimized, average times for preparation drugs and intravenous admixture, and patients' waiting time decreased from 4.84 min, 4.03 min, and 34.33 min to 3.50 min, 2.60 min, and 30.87 min, respectively, patients' satisfaction increased from 66.7% to 93.3%, and the cost of personal protective equipment (PPE) decreased from 46.67 sets and 186.6 CNY per day to 36.17 sets and 144.6 CNY, with statistical significance.

Conclusion: The optimization of the intravenous infusion workflow can effectively decrease the cost of PPE while improving the efficiency of infusion and patients' satisfaction.

Keywords: COVID-19; Drug compounding; Intravenous infusions; Patient satisfaction; Personal protective equipment; Workflow.

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Flowchart showing the optimized intravenous infusion workflow in the isolation ward.

Similar articles

See all similar articles

References

    1. National Health Commission of the People’s Republic of China Latest developments in epidemic control on February 9. http://www.nhc.gov.cn/xcs/yqfkdt/202002/167a0e01b2d24274b03b2ca961107929.shtml, 2020-02-10
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. - PMC - PubMed
    1. National Health Commission of the People’s Republic of China Diagnosis and treatment protocol for novel coronavirus pneumonia. http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml, 2020-02-05 5th Trial Version.
    1. National Health Commission of the People’s Republic of China Technical guidelines for prevention and control of novel coronavirus infection in medical institutions. http://www.nhc.gov.cn/yzygj/s7659/202001/b91fdb7c304431eb082d67847d27e14.shtml, 2020-01-23 (first ed.
    1. National Health Commission of the People’s Republic of China Nursing practice standards for intravenous therapy. http://www.nhc.gov.cn/wjw/pjl/201412/806fe9a7171e4cf584c0d40ed093dfa7.shtml, 2014-05-01
Feedback